October 30, 2026 FDA revises warnings on 3 estradiol patches Cardiovascular, breast cancer, and dementia statements are removed, but other risk information remains. MDSpire News
October 30, 2026 Monthly fasting cycles may be feasible in T2D Nearly 1 in 3 participants discontinued the yearlong dietary program because of diet-related challenges, despite a 61% completion rate. MDSpire News
October 30, 2026 Top 10 evidence-based essentials in ObGyn A structured framework of guidelines, trials, therapies, and tools used in clinical practice. MDSpire News
October 30, 2026 High TIRADS may signal cancer despite benign cytology Patients with higher ultrasound risk classifications had about 5.7 times the adjusted odds of postoperative malignancy in a selected surgical cohort. MDSpire News
October 27, 2026 FDA expands talazoparib use in prostate cancer The combination with enzalutamide reduced the risk of radiographic progression or death by 52% . MDSpire News
October 27, 2026 Inside the $10 Optical Spectrometer The wrist-mounted probe collects near-infrared spectra for exploratory monitoring of human biomarkers The Analytical Scientist
October 26, 2026 FDA expands weekly insulin use to children Insulin icodec-abae offers a weekly basal insulin option for pediatric type 2 diabetes, supported by adult trials and pediatric pharmacokinetic data. MDSpire News
October 26, 2026 Cryptococcal cellulitis may lead to amputation A splinter injury progressed to finger necrosis in a patient with MDS, despite antibacterial treatment and no clinically apparent systemic dissemination. MDSpire News
October 22, 2026 Medical Oddities: When puberty arrives at 4 months old A genetic mystery, hearts in space, midnight munchies, and tea with muscle power are in the lineup this week. MDSpire News
October 21, 2026 Oral spironolactone may hold edge in female acne Topical treatment showed lesion reductions with minimal systemic exposure, but small, heterogeneous studies leave its clinical role uncertain. MDSpire News